Recombinant Human Ccl7 Protein，His

Ccl7, also known as chemokine (C-C motif) ligand 7, is a crucial member of the chemokine family that plays a significant role in immune responses and inflammation. Research on Ccl7 has gained traction due to its involvement in the recruitment of immune cells, particularly monocytes and T cells, to sites of inflammation, which is vital in various pathophysiological conditions such as infection, autoimmune disorders, and cancer. The recombinant protein form of Ccl7 has been extensively studied for its potential applications in therapeutics and diagnostics. By producing Ccl7 in a recombinant form, researchers are able to investigate its biological functions, mechanisms of action, and interactions with chemokine receptors. This recombinant protein also serves as a valuable tool for studying inflammatory processes and the immune system's architecture. Additionally, Ccl7's role in tumor microenvironments has attracted interest in cancer research; understanding its signaling pathways could lead to novel strategies for immunotherapy. Furthermore, as Ccl7 is involved in various diseases, the development of Ccl7 inhibitors might offer new avenues for treatment. Overall, the study of Ccl7 recombinant protein not only enhances our understanding of immune mechanisms but also represents a promising area for the development of new therapeutic strategies. As research in this field advances, it holds the potential to contribute significantly to the management of diseases marked by dysregulated inflammation and immune responses.